145 related articles for article (PubMed ID: 28861778)
1. Purification and Fibrillation of Full-Length Recombinant PrP.
Makarava N; Savtchenko R; Baskakov IV
Methods Mol Biol; 2017; 1658():3-22. PubMed ID: 28861778
[TBL] [Abstract][Full Text] [Related]
2. Purification and fibrillation of full-length recombinant PrP.
Makarava N; Baskakov IV
Methods Mol Biol; 2012; 849():33-52. PubMed ID: 22528082
[TBL] [Abstract][Full Text] [Related]
3. Analysis of Prion Protein Structure Using Nuclear Magnetic Resonance Spectroscopy.
Biljan I; Ilc G; Plavec J
Methods Mol Biol; 2017; 1658():35-49. PubMed ID: 28861781
[TBL] [Abstract][Full Text] [Related]
4. Expression and purification of full-length recombinant PrP of high purity.
Makarava N; Baskakov IV
Methods Mol Biol; 2008; 459():131-43. PubMed ID: 18576153
[TBL] [Abstract][Full Text] [Related]
5. High-Level Production of High-Purity Human and Murine Recombinant Prion Proteins Functionally Compatible to In Vitro Seeding Assay.
Hwang HG; Kim DH; Lee J; Mo Y; Lee SH; Lee Y; Hyeon JW; Lee SM; Cheon YP; Choi EK; Kim SY; Lee YS; Son YJ; Ryou C
J Microbiol Biotechnol; 2018 Oct; 28(10):1749-1759. PubMed ID: 30196595
[TBL] [Abstract][Full Text] [Related]
6. Methods for conversion of prion protein into amyloid fibrils.
Breydo L; Makarava N; Baskakov IV
Methods Mol Biol; 2008; 459():105-15. PubMed ID: 18576151
[TBL] [Abstract][Full Text] [Related]
7. A simple in vitro assay for assessing the efficacy, mechanisms and kinetics of anti-prion fibril compounds.
Ladner-Keay CL; Ross L; Perez-Pineiro R; Zhang L; Bjorndahl TC; Cashman N; Wishart DS
Prion; 2018; 12(5-6):280-300. PubMed ID: 30223704
[TBL] [Abstract][Full Text] [Related]
8. Multiple affinity purification of a baculovirus-derived recombinant prion protein with in vitro ability to convert to its pathogenic form.
Imamura M; Kato N; Iwamaru Y; Mohri S; Yokoyama T; Murayama Y
Prep Biochem Biotechnol; 2017 Jan; 47(1):1-7. PubMed ID: 26918377
[TBL] [Abstract][Full Text] [Related]
9. Generation of a new infectious recombinant prion: a model to understand Gerstmann-Sträussler-Scheinker syndrome.
Elezgarai SR; Fernández-Borges N; Eraña H; Sevillano AM; Charco JM; Harrathi C; Saá P; Gil D; Kong Q; Requena JR; Andréoletti O; Castilla J
Sci Rep; 2017 Aug; 7(1):9584. PubMed ID: 28851967
[TBL] [Abstract][Full Text] [Related]
10. A valine-to-lysine substitution at position 210 induces structural conversion of prion protein into a β-sheet rich oligomer.
Kakuda K; Yamaguchi KI; Kuwata K; Honda R
Biochem Biophys Res Commun; 2018 Nov; 506(1):81-86. PubMed ID: 30336980
[TBL] [Abstract][Full Text] [Related]
11. Improved high-yield expression, purification and refolding of recombinant mammalian prion proteins under aerosol-free elevated biological safety conditions.
Rehbein P; Schwalbe H
Protein Expr Purif; 2018 Oct; 150():53-60. PubMed ID: 29751084
[TBL] [Abstract][Full Text] [Related]
12. Amyloid fibrils from the N-terminal prion protein fragment are infectious.
Choi JK; Cali I; Surewicz K; Kong Q; Gambetti P; Surewicz WK
Proc Natl Acad Sci U S A; 2016 Nov; 113(48):13851-13856. PubMed ID: 27849581
[TBL] [Abstract][Full Text] [Related]
13. Self-Replication of Prion Protein Fragment 89-230 Amyloid Fibrils Accelerated by Prion Protein Fragment 107-143 Aggregates.
Sneideris T; Ziaunys M; Chu BK; Chen RP; Smirnovas V
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33049945
[TBL] [Abstract][Full Text] [Related]
14. Purification and Refolding to Amyloid Fibrils of (His)6-tagged Recombinant Shadoo Protein Expressed as Inclusion Bodies in E. coli.
Li Q; Richard CA; Moudjou M; Vidic J
J Vis Exp; 2015 Dec; (106):e53432. PubMed ID: 26709825
[TBL] [Abstract][Full Text] [Related]
15. Amyloid formation by recombinant full-length prion proteins in phospholipid bicelle solutions.
Lührs T; Zahn R; Wüthrich K
J Mol Biol; 2006 Mar; 357(3):833-41. PubMed ID: 16466741
[TBL] [Abstract][Full Text] [Related]
16. PrP P102L and Nearby Lysine Mutations Promote Spontaneous
Kraus A; Raymond GJ; Race B; Campbell KJ; Hughson AG; Anson KJ; Raymond LD; Caughey B
J Virol; 2017 Nov; 91(21):. PubMed ID: 28835493
[TBL] [Abstract][Full Text] [Related]
17. Optimized overproduction, purification, characterization and high-pressure sensitivity of the prion protein in the native (PrP(C)-like) or amyloid (PrP(Sc)-like) conformation.
Alvarez-Martinez MT; Torrent J; Lange R; Verdier JM; Balny C; Liautard JP
Biochim Biophys Acta; 2003 Feb; 1645(2):228-40. PubMed ID: 12573253
[TBL] [Abstract][Full Text] [Related]
18. Recombinant human prion protein fragment 90-231, a useful model to study prion neurotoxicity.
Corsaro A; Thellung S; Villa V; Nizzari M; Aceto A; Florio T
OMICS; 2012; 16(1-2):50-9. PubMed ID: 22321015
[TBL] [Abstract][Full Text] [Related]
19. Non-reducing alkaline solubilization and rapid on-column refolding of recombinant prion protein.
Walsh DJ; Noble GP; Piro JR; Supattapone S
Prep Biochem Biotechnol; 2012; 42(1):77-86. PubMed ID: 22239709
[TBL] [Abstract][Full Text] [Related]
20. Generating recombinant C-terminal prion protein fragments of exact native sequence.
Johanssen VA; Barnham KJ; Masters CL; Hill AF; Collins SJ
Neurochem Int; 2012 Feb; 60(3):318-26. PubMed ID: 22197912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
